Resmed Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€261.85
Performance (%)
1.55%
Price
02.12.25
€215.90
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 1.55%. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.396% | -2.396% |
| iShares Core DAX® | 0.697% | -0.987% |
| iShares Nasdaq 100 | 1.661% | -1.837% |
| iShares Nikkei 225® | 0.922% | -7.458% |
| iShares S&P 500 | 0.430% | -0.851% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat

